Introduction
Isolated renal artery thrombosis is a rare disease that usually results from systemic embolization and seldom secondary to insitu thrombosis. 1 Management is driven by the clinical presentation, timing and location of the occlusion. Various management options include anticoagulation, systemic thrombolysis, catheter directed thrombolysis or surgery. Recently, ultrasound-enhanced catheter directed thrombolysis has been approved for the management of pulmonary embolism. In our case we have successfully managed isolated renal artery thrombus via ultrasound-enhanced catheter directed thrombolysis.
Case report
A 59-year-old female with past medical history significant for hypertension, diabetes mellitus, coronary artery disease (for which she underwent coronary artery bypass surgery accompanied with mitral and tricuspid valve repair) presented with sudden onset of left sided abdominal pain for 5 hours. Vital signs were significant for a blood pressure of 180/90 mmHg. Electrocardiography showed normal sinus rhythm. Computed tomography of the abdomen and pelvis revealed hypoperfusion of the left kidney with suspicion of left renal artery thrombosis (Fig. A) . Subsequently, abdominal aortogram and selective left renal angiogram showed a total thrombotic occlusion at the proximal segment of the left renal artery (Figs. B, C Videos 1, 2). The Egyptian Heart Journal 70 (2018) 447-450
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The Egyptian Heart Journal j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / e h j Thrombus aspiration was performed ( Fig. D) , followed by ultrasound-enhanced catheter directed thrombolysis using tissue plasminogen activator infusion for 24 hours together with intravenous heparin. The patient's symptoms were completely relieved after thrombolysis. Follow up selective renal angiogram revealed complete resolution of the main renal artery obstruction. However, a residual thrombus was still visualized in the superior segmental artery (Fig. E, Video 3 ).
Hypercoagulable workup was negative, transthoracic and transesophageal echocardiogram showed a reduced ejection fraction of 35% with bi-atrial dilatation. However, there was no apparent source of the embolus. She was started on oral apixaban and was discharged home with a Holter monitor that later on revealed paroxysmal atrial fibrillation.
Discussion
Renal artery embolism can occur secondary to atrial fibrillation, mechanical valve thrombosis, infective endocarditis and thrombi arising from the left ventricular apex or supra renal aorta. 2 Patients usually present with flank pain, generalized abdominal pain, nausea, vomiting, fever or hematuria. On clinical exam, hypertension is common due to acute loss of blood supply to the kidneys leading to the release of excessive renin. 3 Normal renal function is common with unilateral renal artery thrombosis. However, several studies noted that serum lactate dehydrogenase (LDH) is elevated. It has also been shown that LDH elevation with normal aminotransferases is suggestive of renal infarction. [4] [5] [6] Since symptoms can be misleading and due to the absence of a diagnostic laboratory test, many patients are diagnosed after several days of hospitalization. In patients presenting with acute flank pain, computed tomography without contrast is the preferred initial test since it is the gold standard for the diagnosis of kidney and ureteral stones, however it can miss the diagnosis of a renal infarction, hence in patients with suspected renal infarction computed tomography with contrast should be done which classically shows a wedge-shaped perfusion defect. 6 Other diagnostic modalities include magnetic resonance imaging or radioisotope scans, 7 however renal angiography remains the gold standard to establish the diagnosis and determine the etiologies leading to renal infarction. 8 Optimal management of renal artery embolism remains unclear due to the absence of head to head trials of different modalities. The management options include anticoagulation, systemic thrombolysis, catheter directed thrombolysis and surgery.
The time of diagnosis is one of the defining factors indetermination of the therapeutic modality. Several studies showed that the kidney can sustain its viability only for 1-3 hours without any blood supply, [9] [10] [11] other studies showed that intervening within 1-2 days is reasonable and total recovery of the kidney is to be expected due to the presence of collateral circulation. Hence, patients diagnosed several days after the fact or if a shrunken kidney is seen on computed tomography, conservative management via anticoagulation is recommended. However, in patients diagnosed within 2 days of the symptoms a more aggressive approach is recommended. Use of systemic thrombolytic therapy has been established since the late 1950s for myocardial infarctions. 12 In 1970s streptokinase for management of renal artery embolism was introduced, which was proven to be effective but it comes with a high risk of bleeding. 13 In the early 1980s, catheter directed thrombolysis became available, 14 it became more popular as lower doses of thrombolytic agents were used and at the same time, it secured better deliverability of the thrombolytic agent to the culprit site. In 2008, ultrasound-enhanced catheter directed thrombolysis was FDA approved for management of pulmonary embolism. The idea came after Braaten et al. proved that ultrasound exposure causes a reversible disaggregation of fibrin, which facilitates the thrombolysis effect. In addition, ultrasound pressure waves may increase thrombus penetration of thrombolytic drugs by acoustic streaming. 15 Very Few cases of renal artery thrombosis treated via ultrasound-enhanced catheter directed thrombolysis, have been reported, 16 we are reporting that it was proven to be very efficient and safe. However, head to head trials are needed to compare between systemic thrombolysis, catheter directed thrombolysis with and without ultrasound. 
Conclusion
Isolated renal artery thrombosis is rare. The management options include anticoagulation, systemic thrombolysis, catheter directed thrombolysis or surgery. Ultrasound-enhanced catheter directed thrombolysis is currently only approved for management of pulmonary embolism and has rarely been performed for renal artery thrombosis. In this case it was proven to be very effective.
